NutriBand (NTRB) Free Cash Flow (2016 - 2026)
NutriBand (NTRB) posted Free Cash Flow of -$563104.0 for Q2 2026, up 23.06% sequentially from -$731830.0 in Q1 2026, and up 58.05% YoY from -$356284.0 in Q2 2025.
NutriBand (NTRB) Free Cash Flow (2016 - 2026) Analysis & Trends
NutriBand has reported Free Cash Flow for 11 years, with the latest figure at -$563104.0 in Q2 2026.
- Quarterly Free Cash Flow rose 58.05% year-over-year to -$563104.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$4.4 million (up 16.47% YoY) and the FY2026 annual result came in at -$5.1 million, down 8.93% from the prior year.
- Free Cash Flow improved to -$563104.0 in Q2 2026 per NTRB's latest filing, from -$731830.0 in the prior quarter.
- Over five years, Free Cash Flow peaked at -$521715.0 in Q4 2022 and troughed at -$1.8 million in Q4 2025.
- A 5-year average of -$1.0 million and a median of -$963917.0 in 2022 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2022 and 2026: Free Cash Flow tumbled 1418.58% in 2022, then soared 58.05% in 2026.
- Over 5 years, Free Cash Flow stood at -$521715.0 in 2022, then sank by 103.99% to -$1.1 million in 2023, then rose by 0.72% to -$1.1 million in 2024, then slumped by 65.86% to -$1.8 million in 2025, then soared by 67.87% to -$563104.0 in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$563104.0, -$731830.0, and -$1.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -563.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 437.80 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 292.04 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 433.84 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -95.09 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 477.44 Mn |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 | -563,104.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -563,104.00 |
| Apr 30, 2026 | -563,104.00 |
| Jan 31, 2026 | -731,830.00 |
| Jan 31, 2026 | -731,830.00 |
| Oct 31, 2025 | -1.75 Mn |
| Oct 31, 2025 | -1.75 Mn |
| Jul 31, 2025 | -1.31 Mn |
| Jul 31, 2025 | -1.31 Mn |
| Apr 30, 2025 | -1.34 Mn |
| Apr 30, 2025 | -1.34 Mn |
| Jan 31, 2025 | -1.24 Mn |
| Jan 31, 2025 | -1.24 Mn |
| Oct 31, 2024 | -1.06 Mn |
| Oct 31, 2024 | -1.06 Mn |
| Jul 31, 2024 | -1.58 Mn |
| Jul 31, 2024 | -1.58 Mn |
| Apr 30, 2024 | -840,121.00 |
| Apr 30, 2024 | -840,121.00 |
| Jan 31, 2024 | -767,377.00 |
| Jan 31, 2024 | -767,377.00 |